Capital International Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-82,466
Closed -$16.5M 465
2020
Q4
$16.5M Sell
82,466
-71,356
-46% -$14.5M ﹤0.01% 395
2020
Q3
$33.7M Sell
153,822
-386,178
-72% -$81.8M 0.01% 341
2020
Q2
$103M Hold
540,000
0.03% 253
2020
Q1
$83.7M Hold
540,000
0.03% 225
2019
Q4
$45.2M Hold
540,000
0.02% 274
2019
Q3
$36.6M Hold
540,000
0.01% 288
2019
Q2
$35.9M Hold
540,000
0.01% 297
2019
Q1
$30M Hold
540,000
0.01% 310
2018
Q4
$26.8M Sell
540,000
-285,000
-35% -$17.4M 0.01% 291
2018
Q3
$71.2M Buy
+825,000
New +$58.8M 0.03% 245

Other funds holding TDOC

Capital International Investors's TDOC Position: Q1 2021 in Review

Capital International Investors sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 82,466 shares — an estimated $16.5M sold.

Capital International Investors first reported a position in TDOC in Q3 2018 and held it in 10 quarters. The position peaked at $103M in Q2 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Capital International Investors reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Capital International Investors sold 82,466 Teladoc Health shares in Q1 2021, an estimated $16.5M.
  • Capital International Investors first reported a position in Teladoc Health in Q3 2018 and held it in 10 quarters.
  • Capital International Investors's Teladoc Health position peaked at $103M in Q2 2020.
  • 890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.